Skip to content
Abierto

Award notice

PREVENT IDIQ MATO RFP

75N91024D00006

National Institutes of Health, NIH NCI. Research and Development in Biotechnology (except Nanobiotechnology).

Awarded

Weill Medical College of Cornell University

$149,995,000.00 on the award notice, January 24, 2024, contract 75N91024D00006

Description

As published on SAM.gov.

PREVENT EFFICACY Pool: This contract supports the PREVENT Cancer Preclinical Drug Development Program, which provides a structured approach to drug and vaccine development, from discovery to the clinic. This contract is a part of a multiple-award Indefinite Delivery Indefinite Quantity (IDIQ) pool to procure services related to Preclinical Efficacy and Intermediate Endpoint Biomarkers, which is also referred to as the Efficacy Pool.

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

UEI
YNT8TCJH8FQ8
CAGE
1UMU6
Vendor location
New York, NY
Contract
75N91024D00006
Obligated
$0.00, potential $149,995,000
Actions
5 between January 24, 2024 and August 31, 2026
Competition
Full and Open Competition, 9 offers received
Set-aside reported
No Set Aside Used.
Described as
Preclinical Efficacy & Intermediate Endpoint Biomarkers IDIQ Contract in Support of the Prevent Cancer Preclinical Drug Development Program
Match
award number 75N91024D00006 equals the contract number; same awarding office 75N910 (high confidence)

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. January 29, 2024

    Award notice, originally solicitation

    Awarded to WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY New York for $149,995,000. SAM.gov, notice a09e3ba579a54a8c8a4ae3948f2d57ae

  2. January 31, 2024

    Award notice

    Awarded to WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY New York for $149,995,000. SAM.gov, notice 4b33173492c44fccabbf0b4128412ae1

Points of contact